Last reviewed · How we verify
NCT06991244: EQ-EMDR20
EMDR 2.0 Group Therapy for PTSD, Depression, and Anxiety in Earthquake Survivors
NA trial testing EMDR 2.0 Group Protocol in Post-Traumatic Stress Disorder (PTSD) in 58 participants. Completed in 30 December 2024.
10 December 2024
Quick facts
| Lead sponsor | Okan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 58 |
| Start date | 10 October 2024 |
| Primary completion | 10 December 2024 |
| Estimated completion | 30 December 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- EMDR 2.0 Group Protocol
Conditions studied
- Post-Traumatic Stress Disorder (PTSD) — all drugs for Post-Traumatic Stress Disorder (PTSD) →
- Depression — all drugs for Depression →
- Anxiety — all drugs for Anxiety →
Sponsor
Okan University
Who can join
18 and older, female only, with Post-Traumatic Stress Disorder (PTSD) or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this clinical study was to examine whether a brief EMDR 2.0 group intervention could reduce symptoms of post-traumatic stress disorder (PTSD), depression, and anxiety in adult survivors of the 2023 Türkiye earthquake. The study was conducted face-to-face in a container city in Malatya, one of the regions most severely affected by the disaster. EMDR 2.0 is an enhanced version of standard EMDR therapy that uses working memory taxation techniques to accelerate emotional processing. The primary research questions included whether EMDR 2.0 group therapy reduces PTSD symptoms in earthquake survivors, and whether it helps decrease symptoms of depression and anxiety. Participants attended three EMDR 2.0 group sessions in person over the course of one week and completed psychological assessments before the intervention, one week after, and one month after. Verbal disclosure of traumatic memories was not required during the sessions. Researchers used self-report questionnaires to evaluate changes in trauma-related distress, depression, and anxiety. This study contributes to the development of fast, accessible, and field-based psychological support strategies for communities affected by disasters.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06991244
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-Traumatic Stress Disorder (PTSD)
Currently open trials in the same condition.
- NCT06194851 — Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD · Phase 2 · recruiting
Other Okan University trials
Trials by the same sponsor.
- NCT07457034 — Digital Follow-Up and Nursing Education in Bariatric Surgery Patients · NA · not yet recruiting
- NCT07457905 — THE RELATIONSHIP BETWEEN PAIN ANXIETY AND POST-OPERATIVE PAIN IN PATIENTS UNDERGOING CHOLECYSTECTOMY SURGERY · not yet recruiting
- NCT07462832 — Effect of Connective Tissue Massage in Low Back Pain · NA · not yet recruiting
- NCT07408401 — Exercise Program Combined With Ergonomic Training in Textile Workers · NA · not yet recruiting
- NCT07276126 — The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlle · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06991244 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Okan University
- Last refreshed: 31 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06991244.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing